| Print
ABBVIE (ABBV)
Common StockNot yet a customer?
Low cost dealing from £1.50Choose from our range of SIPP, ISA and Dealing accounts
Find out moreThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan addedseveral new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Address
1 North Waukegan Road
North Chicago
IL
USA
60064-6400
Telephone
+1 847 9327900
Forecast key dates
| Name | Key Date |
|---|---|
| AbbVie Inc Third Quarter Earnings Conference Call for 2026 | 2026-10-30T08:00:00 |
| AbbVie Inc Third Quarter Earnings Results for 2026 | 2026-10-30T00:00:00 |
| AbbVie Inc Second Quarter Earnings Conference Call for 2026 | 2026-07-31T08:00:00 |
| AbbVie Inc Second Quarter Earnings Results for 2026 | 2026-07-31T00:00:00 |
| AbbVie Inc Annual General Meeting for 2026 | 2026-05-08T09:00:00 |
| AbbVie Inc First Quarter Earnings Conference Call for 2026 | 2026-04-24T08:00:00 |
| AbbVie Inc First Quarter Earnings Results for 2026 | 2026-04-24T00:00:00 |
| AbbVie Inc Annual Report for 2025 | 2026-02-13T00:00:00 |
| AbbVie Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-01-30T08:00:00 |
| AbbVie Inc Fourth Quarter Earnings Results for 2025 | 2026-01-30T00:00:00 |
| AbbVie Inc Third Quarter Earnings Conference Call for 2025 | 2025-10-31T08:00:00 |
| AbbVie Inc Third Quarter Earnings Results for 2025 | 2025-10-31T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.